These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16688298)

  • 21. Introduction: treatment of Gram-positive infections.
    Wise R
    J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii5-7. PubMed ID: 12797336
    [No Abstract]   [Full Text] [Related]  

  • 22. Daptomycin, a lipopeptide antibiotic in clinical practice.
    Weis F; Beiras-Fernandez A; Schelling G
    Curr Opin Investig Drugs; 2008 Aug; 9(8):879-84. PubMed ID: 18666036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epidemiology of multiresistance in Gram-negative non-fermenting bacilli].
    Calvo J
    Rev Esp Quimioter; 2006 Mar; 19(1):86. PubMed ID: 16688299
    [No Abstract]   [Full Text] [Related]  

  • 24. [Alloiococcus otitidis: a more common microorganism than we thought?].
    Josebe Unzaga M; Rojo P; Pardo C; Melero P; Cisterna R
    Enferm Infecc Microbiol Clin; 1997 Mar; 15(3):174-5. PubMed ID: 9235069
    [No Abstract]   [Full Text] [Related]  

  • 25. Experience with linezolid therapy in children with osteoarticular infections.
    Chen CJ; Chiu CH; Lin TY; Lee ZL; Yang WE; Huang YC
    Pediatr Infect Dis J; 2007 Nov; 26(11):985-8. PubMed ID: 17984803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci.
    Leclercq R
    Clin Microbiol Infect; 2009 Mar; 15(3):224-31. PubMed ID: 19335370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.
    Zhanel GG; DeCorby M; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; Mulvey MR; Hoban DJ;
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):67-80. PubMed ID: 18513913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical impact of antibiotic-resistant Gram-positive pathogens.
    Lode HM
    Clin Microbiol Infect; 2009 Mar; 15(3):212-7. PubMed ID: 19335368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
    Lin DF; Zhang YY; Wu JF; Wang F; Zheng JC; Miao JZ; Zheng LY; Sheng RY; Zhou X; Shen HH; Ijzerman MM; Croos-Dabrera RV; Sheng W
    Int J Antimicrob Agents; 2008 Sep; 32(3):241-9. PubMed ID: 18635341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infections caused by Gemella spp.: case reports from India.
    Chaudhry R; Mathur P; Dhawan B; Gaur S; Dey AB
    J Infect; 2001 Aug; 43(2):152-5. PubMed ID: 11676525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance.
    Jones RN; Kirby JT; Rhomberg PR
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):203-13. PubMed ID: 18329835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo antibacterial evaluation of DRF 8417, a new oxazolidinone.
    Sreenivas K; Amarnath PV; Mallik A; Sarnaik H; Kumar NS; Takhi M; Trehan S; Kumar MS; Iqbal J; Rajagopalan R; Chakrabarti R
    J Antimicrob Chemother; 2007 Jul; 60(1):159-61. PubMed ID: 17449889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.
    Farajnia S; Alikhani MY; Ghotaslou R; Naghili B; Nakhlband A
    Int J Infect Dis; 2009 Mar; 13(2):140-4. PubMed ID: 18703368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Moet GJ; Jones RN; Biedenbach DJ; Stilwell MG; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):7-13. PubMed ID: 17059876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence and spread of antibiotic-resistant Gram-positive bacterial pathogens.
    Witte W; Cuny C; Klare I; Nübel U; Strommenger B; Werner G
    Int J Med Microbiol; 2008 Jul; 298(5-6):365-77. PubMed ID: 18325835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of pediatric Gram-positive multidrug-resistant infections.
    Blumer J
    J Infect; 2009 Sep; 59 Suppl 1():S51-8. PubMed ID: 19766890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Septicaemia caused by Pediococcus pentosaceus: a new opportunistic pathogen.
    Corcoran GD; Gibbons N; Mulvihill TE
    J Infect; 1991 Sep; 23(2):179-82. PubMed ID: 1753117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-staphylococcal Gram-positive bacteraemia without a known source.
    Hoen B
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S15-7. PubMed ID: 18819777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelets interact with bacterial pathogens.
    Shannon O
    Thromb Haemost; 2009 Oct; 102(4):613-4. PubMed ID: 19806244
    [No Abstract]   [Full Text] [Related]  

  • 40. European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci.
    Brazier J; Chmelar D; Dubreuil L; Feierl G; Hedberg M; Kalenic S; Könönen E; Lundgren B; Malamou-Ladas H; Nagy E; Sullivan A; Nord CE;
    Int J Antimicrob Agents; 2008 Apr; 31(4):316-20. PubMed ID: 18180149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.